ANET vs. KNSA
ANET (Arista Networks, Inc.) and KNSA (Kiniksa Pharmaceuticals, Ltd.) are both stocks. ANET operates in Computer Hardware (Technology), while KNSA operates in Biotechnology (Healthcare). Over the past 5 years, ANET returned 49.97%/yr vs 37.13%/yr for KNSA. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
ANET vs. KNSA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANET achieves a 37.64% return, which is significantly lower than KNSA's 80.22% return.
ANET
- 1D
- 5.46%
- 1M
- 8.24%
- 6M
- 27.24%
- YTD
- 37.64%
- 1Y
- 46.36%
- 3Y*
- 57.23%
- 5Y*
- 49.97%
- 10Y*
- 45.01%
- ALL TIME*
- 38.48%
KNSA
- 1D
- -4.94%
- 1M
- 18.22%
- 6M
- 69.26%
- YTD
- 80.22%
- 1Y
- 145.67%
- 3Y*
- 57.85%
- 5Y*
- 37.13%
- 10Y*
- —
- ALL TIME*
- 14.55%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.09B | $1.31B | $1.55B | |
| $68.75M | $54.52M | $46.86M |
ANET vs. KNSA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ANET Arista Networks, Inc. | 37.64% | 18.55% | 87.73% | 94.07% | -15.58% | 97.89% | 42.86% | -3.46% | -17.69% |
KNSA Kiniksa Pharmaceuticals, Ltd. | 80.22% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -60.63% | 14.89% |
Correlation
The correlation between ANET and KNSA is -0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.09 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.16 |
Correlation (All Time) Calculated using the full available price history since May 24, 2018 | 0.19 |
The correlation between ANET and KNSA shifts across timeframes, from -0.07 (1 year) to 0.19 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ANET:
$227.09B
KNSA:
$5.67B
ANET:
$2.92
KNSA:
$1.00
ANET:
61.82
KNSA:
74.38
ANET:
1.45
KNSA:
0.72
ANET:
23.69
KNSA:
7.14
ANET:
17.03
KNSA:
9.48
ANET:
$9.71B
KNSA:
$840.85M
ANET:
$6.17B
KNSA:
$546.22M
ANET:
$4.21B
KNSA:
$111.62M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANET vs. KNSA — Risk / Return Rank
ANET
KNSA
ANET vs. KNSA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arista Networks, Inc. (ANET) and Kiniksa Pharmaceuticals, Ltd. (KNSA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANET | KNSA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.12 | ||
| Sortino ratioReturn per unit of downside risk | -2.73 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.52 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.64 | 6.94 | -5.30 |
| Martin ratioReturn relative to average drawdown | 3.37 | 24.13 | -20.76 |
Loading charts...
Drawdowns
ANET vs. KNSA - Drawdown Comparison
The maximum ANET drawdown since its inception was -52.20%, smaller than the maximum KNSA drawdown of -83.06%. Use the drawdown chart below to compare losses from any high point for ANET and KNSA.
Loading charts...
Drawdown Indicators
| ANET | KNSA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.20% | -83.06% | +30.86% |
Max Drawdown (1Y)Largest decline over 1 year | -28.33% | -21.12% | -7.21% |
Max Drawdown (3Y)Largest decline over 3 years | -50.42% | -34.14% | -16.28% |
Max Drawdown (5Y)Largest decline over 5 years | -50.42% | -53.17% | +2.75% |
Max Drawdown (10Y)Largest decline over 10 years | -52.20% | — | — |
Current DrawdownCurrent decline from peak | -3.54% | -8.13% | +4.59% |
Average DrawdownAverage peak-to-trough decline | -15.30% | -40.09% | +24.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.82% | 6.06% | +7.76% |
Volatility
ANET vs. KNSA - Volatility Comparison
The current volatility for Arista Networks, Inc. (ANET) is 19.95%, while Kiniksa Pharmaceuticals, Ltd. (KNSA) has a volatility of 26.47%. This indicates that ANET experiences smaller price fluctuations and is considered to be less risky than KNSA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANET | KNSA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.95% | 26.47% | -6.52% |
Volatility (6M)Calculated over the trailing 6-month period | 43.19% | 41.55% | +1.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.22% | 49.77% | +6.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.29% | 54.77% | -6.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.33% | 64.34% | -19.01% |
Dividends
ANET vs. KNSA - Dividend Comparison
Neither ANET nor KNSA has paid dividends to shareholders.
Financials
ANET vs. KNSA - Financials Comparison
This section allows you to compare key financial metrics between Arista Networks, Inc. and Kiniksa Pharmaceuticals, Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ANET vs. KNSA - Profitability Comparison
ANET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Arista Networks, Inc. reported a gross profit of 1.68B and revenue of 2.71B. Therefore, the gross margin over that period was 61.9%.
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 220.03M and revenue of 243.60M. Therefore, the gross margin over that period was 90.3%.
ANET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Arista Networks, Inc. reported an operating income of 1.16B and revenue of 2.71B, resulting in an operating margin of 42.7%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 27.19M and revenue of 243.60M, resulting in an operating margin of 11.2%.
ANET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Arista Networks, Inc. reported a net income of 1.02B and revenue of 2.71B, resulting in a net margin of 37.8%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 25.43M and revenue of 243.60M, resulting in a net margin of 10.4%.
Frequently Asked Questions
ANET and KNSA have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KNSA has higher volatility (26.47%) compared to ANET (19.95%). In terms of maximum drawdown, ANET dropped -52.20% vs KNSA's -83.06%.
KNSA currently has the higher Sharpe Ratio (2.94 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANET and KNSA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer